Editor’s Choice: A New CRISPR Trial, Revelations About Zika-Related GBS, and Parents Taking Action

Happy Thursday! This week, we have details on the beginnings of a new trial testing CRISPR gene editing for Duchenne muscular dystrophy, how parents can play a critical role in…

Continue Reading Editor’s Choice: A New CRISPR Trial, Revelations About Zika-Related GBS, and Parents Taking Action
Study of the Week: Zika Virus-Related Guillain-Barre Syndrome Linked to Worsened Olfactory Function
source: pixabay.com

Study of the Week: Zika Virus-Related Guillain-Barre Syndrome Linked to Worsened Olfactory Function

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Zika Virus-Related Guillain-Barre Syndrome Linked to Worsened Olfactory Function
GBS from Zika Virus Linked to Poor Olfactory Function
ckstockphoto / Pixabay

GBS from Zika Virus Linked to Poor Olfactory Function

Postnatal Zika virus can cause other complications and health issues for those affected. According to Neurology Advisor, one such complication is Guillain-Barré syndrome (GBS). Researchers believe that GBS following postnatal…

Continue Reading GBS from Zika Virus Linked to Poor Olfactory Function
Atypical Form of Guillain-Barré Syndrome Found Following COVID-19 Vaccination
source: pixabay.com

Atypical Form of Guillain-Barré Syndrome Found Following COVID-19 Vaccination

Two new reports of Guillain-Barré syndrome (GBS) have been documented in response to the AstraZeneca COVID-19 vaccine. Previously, published papers have documented 4 cases in England and 7 cases in…

Continue Reading Atypical Form of Guillain-Barré Syndrome Found Following COVID-19 Vaccination
Intravenous Immunoglobulin (IVIG) as a Treatment for Neurological Disorders
source: pixabay.com

Intravenous Immunoglobulin (IVIG) as a Treatment for Neurological Disorders

Intravenous immunoglobulin (IVIG) has been used to treat autoimmune conditions for years, and it is now being explored as a treatment for certain neurological diseases. Recent research has investigated IVIG…

Continue Reading Intravenous Immunoglobulin (IVIG) as a Treatment for Neurological Disorders
May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness

The month of May is recognized as Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) awareness month, a time set aside to spread awareness about these rare conditions among…

Continue Reading May is GBS and CIDP Awareness Month: Spreading Rare Disease Awareness
Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
source: pixabay.com

Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19

In a case study published on dovepress.com, a 17 year old girl diagnosed with COVID-19 developed Guillain-Barre syndrome, a neurological disease causing muscle weakness, as her symptoms progressed. While COVID-19…

Continue Reading Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
How COVID-19, Chronic Fatigue Syndrome, and Guillain-Barre Syndrome are Linked
source: pixabay.com

How COVID-19, Chronic Fatigue Syndrome, and Guillain-Barre Syndrome are Linked

We have learned a lot, but still have much to learn about COVID-19. Researchers have seen a link between COVID-19 and chronic fatigue syndrome (myalgic encephalomyelitis) as well as Guillain-Barre syndrome, which…

Continue Reading How COVID-19, Chronic Fatigue Syndrome, and Guillain-Barre Syndrome are Linked
FDA Approves Investigational New Drug Application For an Experimental Treatment for Guillain-Barre Syndrome
RobinHiggins / Pixabay

FDA Approves Investigational New Drug Application For an Experimental Treatment for Guillain-Barre Syndrome

According to a story from BioSpace, the biotechnology company Cellenkos, Inc., recently announced that the US Food and Drug Administration (FDA) has given the company the go ahead to begin…

Continue Reading FDA Approves Investigational New Drug Application For an Experimental Treatment for Guillain-Barre Syndrome

Vacation Gone Wrong: Teen Opens Up About Her Sudden Paralysis Due to Rare Disease

People Magazine published an article about 20-year-old Kara Dunn who suddenly became paralyzed during a vacation to Spain, due to a rare disease she didn't know she had. Guillain-Barré Syndrome…

Continue Reading Vacation Gone Wrong: Teen Opens Up About Her Sudden Paralysis Due to Rare Disease
New Evidence Uncovered Connecting Risk Factors Between Zika Virus and Guillain-Barré syndrome
Source: Pixabay

New Evidence Uncovered Connecting Risk Factors Between Zika Virus and Guillain-Barré syndrome

New findings are coming from a recent study led by researchers at the Journal of the American Medical Association (JAMA) that could have long-term implications for Zika Virus research. Evidence showed that…

Continue Reading New Evidence Uncovered Connecting Risk Factors Between Zika Virus and Guillain-Barré syndrome